Linsitinib (OSI-906) is a potent, selective and orally bioavailable dual inhibitor of the IGF-1 receptor and insulin receptor (IR) with IC50s of 35 and 75 nM, respectively[1].
Molecular Weight:
421.49
Purity:
99.87
CAS Number:
[867160-71-2]
Formula:
C26H23N5O
Target:
IGF-1R,Insulin Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted